Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Spironolactone may help improve symptoms and tear quality in dry eye disease.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Testosterone may slow down wound healing and increase inflammation.

Anabolic steroid users may face higher risk of severe COVID-19.

Hsc70 protein may influence hair growth by responding to androgens.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Extracts improve hair growth in alopecia.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Minoxidil and finasteride effectively treat hair loss.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Multiple treatments work best for hair loss.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.